EUCTR2004-003783-30-DE进行中（未招募）不适用
Application of Aprepitant as salvage prophylaxis after failure of a conventional antiemetic therapy during moderately emetogenic chemotherapy in gastrointestinal cancer - EMEND_GI
Technical Unversity of Munich0 个研究点开始时间: 2005年2月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Treatment of any tumor in the gastrointestinal tract with moderately emetogenic chemotherapy.
- •Failure of a adequate standard prophylaxis
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Treatment of any tumor in the gastrointestinal tract with delayed CINV after day 5.
- •Past treatment with CINV >/= degree 2.
- •Known incompatibility compared to study medication.
- •Failure competency of the patient as to protocol instruction.
- •Patients with childbearing potential or lactation.
研究者
相似试验
招募中
不适用
Efficacy and safety of Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with hematological malignancies after highly emetogenic chemotherapyhematological malignanciesJPRN-UMIN000005624Tokushima University Hospital100
招募中
3 期
Evaluation of the efficacy of Aprepitant in vomiting of children with cancerMalignant cancer.Agranulocytosis secondary to cancer chemotherapyD70.1IRCT20200204046377N1Shahid Beheshti University of Medical Sciences30
已完成
3 期
The safety and efficacy of Aprepitant to the prevention of chemotherapy-induced nausea and vomitingIRCT20200819048455N1Iran University of Medical Sciences85
进行中（未招募）
不适用
Aprepitant for prevention of acute and delayed nausea and vomiting: a phase III, double-blind, randomized, palcebo-controlled trial in patients receiving a high-emetogenic dose of cyclophosphamide for peripheral blood stem cells harvesting - NDEUCTR2009-017603-28-ITAZIENDA OSPEDALIERA DI PERUGIA
招募中
1 期
The efficacy of aprepitant for the prevention of postoperative nausea and vomiting after bariatric surgery.Postoperative nausea and vomitingCTIS2023-508849-40-00niversity Of Tartu260